Case Report
Published on 02 Apr 2025
Anlotinib induced type 1 diabetes: a case report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1508645
- 107 views
Type at least 3 characters
1,046 articles
Case Report
Accepted on 31 Mar 2025
A case report of a spherical mass in the right atrium: myxoma or thrombus?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1581972
Case Report
Published on 31 Mar 2025
Laryngeal sarcomatoid carcinoma: a case report and literature review on potential molecular targets for therapeutic opportunities
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1549790
- 169 views
Original Research
Published on 28 Mar 2025
MiR-146b overexpression promotes bladder cancer cell growth via the SMAD4/C-MYC/Cyclin D1 axis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1565638
- 235 views
Systematic Review
Accepted on 26 Mar 2025
Efficacy and safety of immune checkpoint inhibitors for brain metastases of non-small cell lung cancer: A systematic review and network meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1513774
Retraction
Published on 25 Mar 2025
Retraction: Dihydroartemisinin suppresses the tumorigenesis and cycle progression of colorectal cancer by targeting CDK1/CCNB1/PLK1 signaling
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1591122
- 223 views
Original Research
Published on 25 Mar 2025
GART promotes the proliferation and migration of human non-small cell lung cancer cell lines A549 and H1299 by targeting PAICS-Akt-β-catenin pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1543463
- 194 views
Original Research
Accepted on 24 Mar 2025
Acute Aerobic Exercise Alters Serum Protein Distribution in Colorectal Cancer Patients
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1586344
Original Research
Accepted on 24 Mar 2025
Targeting the Dual miRNA/BMP2 Network: LncRNA H19-Mediated Temozolomide Resistance Unveils Novel Therapeutic Strategies in Glioblastoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1577221
Editorial
Published on 24 Mar 2025
Editorial: Immunomodulatory molecules of natural origin: innovative strategies for combatting cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1568568
- 222 views
Original Research
Accepted on 21 Mar 2025
Predictive Significance of 18 F-FDG PET/CT Metabolic Parameters for the Expression Level of HER2 in Gastric Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1580166
Original Research
Published on 21 Mar 2025
The effect of deuterated PLK1 inhibitor on its safety and efficacy in vivo
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1510052
- 352 views
Original Research
Published on 19 Mar 2025
Real-world analysis of leuprorelin acetate microspheres-based neoadjuvant therapy for patients with high-risk prostate cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1520370
- 360 views
Original Research
Published on 18 Mar 2025
Uncovering the heterogeneity of NK cells on the prognosis of HCC by integrating bulk and single-cell RNA-seq data
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1570647
- 361 views
Original Research
Published on 06 Mar 2025
Application of a multifunctional chemotherapy infusion device for reducing antineoplastic drug extravasation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1539389
- 254 views
Review
Published on 20 Feb 2025
Reversal of chemotherapy resistance in gastric cancer with traditional Chinese medicine as sensitizer: potential mechanism of action
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1524182
- 659 views